Role of Pharmacists in Antimicrobial Stewardship During COVID-19 Outbreak: A Scoping Review

References

• Collective remembering and future forecasting during the COVID-19 pandemic: how the impact of COVID-19 affected the themes and phenomenology of global and national memories across 15 countries - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/35817990/. Accessed November 3, 2022.
   Google Scholar
• Badreldin HA, Atallah B. Global drug shortages due to COVID-19: impact on patient care and mitigation strategies. Res Soc Adm Pharm. 2021;17:1946–1949. doi:10.1016/j.sapharm.2020.05.017
   PubMed Web of Science ®Google Scholar
• Caren GJ, Iskandar D, Pitaloka DAE, Abdulah R, Suwantika AA. COVID-19 pandemic disruption on the management of tuberculosis treatment in Indonesia. J Multidiscip Healthc. 2022;15:175–183. doi:10.2147/JMDH.S341130
   PubMed Web of Science ®Google Scholar
• Rezel-Potts E, L’Esperance V, Gulliford MC. Antimicrobial stewardship in the UK during the COVID-19 pandemic: a population-based cohort study and interrupted time-series analysis. Br J Gen Pract J R Coll Gen Pract. 2021;71:e331–e338. doi:10.3399/BJGP.2020.1051
   PubMed Web of Science ®Google Scholar
• Islam N, Ebrahimzadeh S, Salameh JP, et al. Antibiotics for the treatment of COVID-19. Cochrane Database Syst Rev. 2021;10. doi:10.1002/14651858.CD013639.pub4.
   Web of Science ®Google Scholar
• Hawes L, Buising K, Mazza D. Antimicrobial stewardship in general practice: a scoping review of the component parts. Antibiot Basel Switz. 2020;9:498.
   PubMed Web of Science ®Google Scholar
• Owens RC. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis. 2008;61:110–128. doi:10.1016/j.diagmicrobio.2008.02.012
   PubMed Web of Science ®Google Scholar
• CDC. COVID-19 & Antibiotic Resistance. Centers for Disease Control and Prevention; 2022. Available from: https://www.cdc.gov/drugresistance/covid19.html. Accessed November 3, 2022.
   Google Scholar
• Lynch C, Mahida N, Gray J. Antimicrobial stewardship: a COVID casualty? J Hosp Infect. 2020;106:401–403. doi:10.1016/j.jhin.2020.10.002
   PubMed Web of Science ®Google Scholar
• Bardi T, Pintado V, Gomez-Rojo M, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2021;40:495–502. doi:10.1007/s10096-020-04142-w
   PubMed Web of Science ®Google Scholar
• van der Eerden MM, Vlaspolder F, De Graaff CS, et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60:672–678. doi:10.1136/thx.2004.030411
   PubMed Web of Science ®Google Scholar
• Mayi BS, Mainville M, Altaf R. A crucial role for antimicrobial stewardship in the midst of COVID-19. J Microbiol Amp Biol Educ. 2021;22:ev22i1.2285. doi:10.1128/jmbe.v22i1.2285
   Google Scholar
• Weiner-Lastinger LM, Abner S, Edwards JR, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the national healthcare safety network, 2015–2017. Infect. Control Hosp. Epidemiol. 2020;41:1–18. doi:10.1017/ice.2019.296
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
   PubMed Web of Science ®Google Scholar
• Elbeddini A, Prabaharan T, Almasalkhi S, Tran C. Pharmacists and COVID-19. J Pharm Policy Pract. 2020;13(36). doi:10.1186/s40545-020-00241-3
   Google Scholar
• Jones KA, Watson M, Jacob JT, Wiley Z. Antimicrobial stewardship interventions to minimize healthcare worker exposure to SARS-CoV-2. Infect Control Hosp Epidemiol. 2021;42:645–646. doi:10.1017/ice.2020.302
   PubMed Web of Science ®Google Scholar
• Goldstein EJC, Tillotson G, Redell M. Antimicrobial management of respiratory infections in severe acute respiratory syndrome coronavirus 2 patients: clinical and antimicrobial stewardship programs conundrums. Open Forum Infect Dis. 2020;7:1–5. doi:10.1093/ofid/ofaa517
   Web of Science ®Google Scholar
• Goff DA, Ashiru‐Oredope D, Cairns KA, et al. Global contributions of pharmacists during the COVID −19 pandemic. J Am Coll Clin Pharm. 2020;3:1480–1492. doi:10.1002/jac5.1329
   PubMedGoogle Scholar
• Collins CD, West N, Sudekum DM, Hecht JP. Perspectives from the frontline: a pharmacy department’s response to the COVID-19 pandemic. Am J Health Syst Pharm. 2020;77:1409–1416. doi:10.1093/ajhp/zxaa176
   PubMed Web of Science ®Google Scholar
• Liu YX, Liang C, Yang Y, et al. Reduction in antimicrobial use associated with a multifaceted antimicrobial stewardship programme in a tertiary teaching hospital in shanghai: a segmented regression analysis. Ann. Palliat. Med. 2021;10:7360–7369. doi:10.21037/apm-21-700
   PubMed Web of Science ®Google Scholar
• Alnajjar MS, ZainAlAbdin S, Arafat M, Skaik S, AbuRuz S. Pharmacists’ knowledge, attitude and practice in the UAE toward the public health crisis of COVID-19: a cross-sectional study. Pharm Pract. 2022;20:2628.
   PubMed Web of Science ®Google Scholar
• Al Qamariat Z, Almaghaslah D. Pharmacists’ perceptions of handling antimicrobial resistance (Amr): a case study in Saudi Arabia. Infect Drug Resist. 2021;14:4517–4528. doi:10.2147/IDR.S336994
   PubMed Web of Science ®Google Scholar
• Ng TM, Tan SH, Heng ST, et al. Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore. Antimicrob Resist Infect Control. 2021;10:1–8. doi:10.1186/s13756-021-00898-8
   PubMed Web of Science ®Google Scholar
• Al-Quteimat O, Siddiqui M, Hussein L, Al Emleh H, Shamieh IED. Analysis of pharmacist interventions in adult COVID-19 patients admitted to a tertiary care hospital. J Pharm Pract. 2022;8971900211065536. doi:10.1177/08971900211065536
   Web of Science ®Google Scholar
• Schmid S, Schlosser S, Gülow K, et al. Interprofessional collaboration between ICU physicians, staff nurses, and hospital pharmacists optimizes antimicrobial treatment and improves quality of care and economic outcome. Antibiot Basel Switz. 2022;11:381.
   PubMed Web of Science ®Google Scholar
• Ashiru-Oredope D, Kerr F, Hughes S, et al. Assessing the impact of COVID-19 on antimicrobial stewardship activities/programs in the United Kingdom. Antibiot Basel Switz. 2021;10:110.
   PubMed Web of Science ®Google Scholar
• Ashiru-Oredope D, Chan AHY, Olaoye O, et al. Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countries. J Pharm Policy Pract. 2020;13(72). doi:10.1186/s40545-020-00275-7
   Google Scholar
• Marwitz KK. The pharmacist’s active role in combating COVID-19 medication misinformation. J Am Pharm Assoc JAPhA. 2021;61:e71–e74. doi:10.1016/j.japh.2020.10.022
   PubMed Web of Science ®Google Scholar
• Parreiras Martins MA, Fonseca de Medeiros A, Dias Carneiro de Almeida C, Moreira Reis AM. Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview. Drugs Ther Perspect. 2020;36:455–462. doi:10.1007/s40267-020-00761-7
   PubMedGoogle Scholar
• Arabi YM, Azoulay E, Al-Dorzi HM, et al. How the COVID-19 pandemic will change the future of critical care. Intensive Care Med. 2021;47:282–291. doi:10.1007/s00134-021-06352-y
   PubMed Web of Science ®Google Scholar
• Poh A-L, Lin W. Role of the pharmacist during the COVID-19 pandemic: a time to rethink strategies. Singapore Med J. 2021;62:315–317. doi:10.11622/smedj.2020098
   PubMed Web of Science ®Google Scholar
• Pennsylvania DM, Maryland Jason C. The Pharmacist’s Role in Preventing Antibiotic Resistance. Available from: https://www.uspharmacist.com/article/the-pharmacists-role-in-preventing-antibiotic-resistance. Accessed November 3, 2022.
   Google Scholar
• Mas-Morey P, Ballesteros-Fernández A, Sanmartin-Mestre E, Valle M. Impact of clinical pharmacist intervention on antimicrobial use in a small 164-bed hospital. Eur J Hosp Pharm Sci Pract. 2018;25:e46–e51. doi:10.1136/ejhpharm-2017-001307
   PubMedGoogle Scholar
• Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27:520–531.
   PubMed Web of Science ®Google Scholar
• Mazdeyasna H, Nori P, Patel P, et al. Antimicrobial stewardship at the core of COVID-19 response efforts: implications for sustaining and building programs. Curr Infect Dis Rep. 2020;22:23. doi:10.1007/s11908-020-00734-x
   PubMed Web of Science ®Google Scholar
• Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: challenges and opportunities - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/33543233/. Accessed November 3, 2022.
   Google Scholar
• Pierce J, Stevens MP. COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications. Int J Infect Dis IJID off Publ Int Soc Infect Dis. 2021;113:103–108.
   PubMed Web of Science ®Google Scholar
• Huang JA, Hartanti IR, Colin MN, Pitaloka DA. Telemedicine and artificial intelligence to support self-isolation of COVID-19 patients: recent updates and challenges. Digit Health. 2022;8:20552076221100630.
   Web of Science ®Google Scholar
• Kane-Gill SL, Niznik JD, Kellum JA, et al. Use of telemedicine to enhance pharmacist services in the nursing facility. Consult Pharm J Am Soc Consult Pharm. 2017;32:93–98.
   PubMedGoogle Scholar
• Solomon DH, Bucala R, Kaplan MJ, Nigrovic PA. The ‘Infodemic’ of COVID-19. Arthritis Rheumatol Hoboken NJ. 2020;72:1806–1808. doi:10.1002/art.41468
   PubMed Web of Science ®Google Scholar
• Pantasri T. Expanded roles of community pharmacists in COVID-19: a scoping literature review. J Am Pharm Assoc. 2003;62:649–657.
   Google Scholar
• Parente DM, Morton J. Role of the pharmacist in antimicrobial stewardship. Med Clin North Am. 2018;102:929–936. doi:10.1016/j.mcna.2018.05.009
   PubMed Web of Science ®Google Scholar
• Garau J, Bassetti M. Role of pharmacists in antimicrobial stewardship programmes. Int J Clin Pharm. 2018;40:948–952. doi:10.1007/s11096-018-0675-z
   PubMed Web of Science ®Google Scholar